DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Digital Insights (1321)

Nonadherence: an ongoing epidemic | ePharma Consumer 2016 | Module

Nonadherence: an ongoing epidemic | ePharma Consumer 2016 | Module

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

Medical nonadherence is an infamously expensive detriment to public health, costing pharmaceutical companies billions in lost revenues and leading to poorer patient outcomes. This report looks into what tactics pharma should use to improve patient adherence.

Questions Answered in This Report:

    • What are the key roadblocks to adherence?
    • How can pharma brands help to maximize patient adherence to their medicines?
    • How important is health literacy in promoting patient adherence? What is the impact of behavioral health coaching?
    • What technology-enabled tools and services improve adherence and patient outcomes? 

Already a Client? Log in to access this report.

  • Pub Date: July 2017

Become a DRG client

Recent reports:
You may also be interested in: